Green tea extract inhibits chemokine production, but up-regulates chemokine receptor expression, in rheumatoid arthritis synovial fibroblasts and rat adjuvant-induced arthritis-Reference-Cited by-同舟云学术

Green tea extract inhibits chemokine production, but up-regulates chemokine receptor expression, in rheumatoid arthritis synovial fibroblasts and rat adjuvant-induced arthritis

Published:2009-12-23 Issue:3 Volume:49 Page:467-479
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Marotte H.,Ruth J. H.,Campbell P. L.,Koch A. E.,Ahmed S.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/49/3/467/5052751/kep397.pdf

Reference50 articles.

1. Chemokines and their receptors in rheumatoid arthritis: Future targets?

2. Clinical responses to tumor necrosis factor ? antagonists do not show a bimodal distribution: Data from the Stockholm Tumor Necrosis Factor ? Followup Registry

3. Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept

4. The shared epitope is a marker of severity associated with selection for, but not with response to, infliximab in a large rheumatoid arthritis population

5. Chemokine/Chemokine Receptor Nomenclature

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TRPM7 facilitates fibroblast-like synoviocyte proliferation, metastasis and inflammation through increasing IL-6 stability via the PKCα-HuR axis in rheumatoid arthritis;International Immunopharmacology;2024-05

2. Flavonoids and Flavonoid-Based Nanoparticles for Osteoarthritis and Rheumatoid Arthritis Management;BioChem;2024-03-13

3. Phytochemicals and Their Usefulness in the Maintenance of Health;Plants;2024-02-15

4. Potential mechanism of tea for treating osteoporosis, osteoarthritis, and rheumatoid arthritis;Frontiers in Medicine;2024-02-14

5. Nano-platform Strategies of Herbal Components for the management of Rheumatoid Arthritis: A Review on the Battle for Next-Generation Formulations;Current Drug Delivery;2023-08-25